Insider Buying: GE HealthCare Technologies (NASDAQ:GEHC) Director Buys 10,000 Shares of Stock

GE HealthCare Technologies Inc. (NASDAQ:GEHC) Director Kevin Lobo acquired 10,000 shares of the stock in a transaction that occurred on Friday, May 22nd. The shares were bought at an average price of $64.18 per share, with a total value of $641,800.00. Following the completion of the purchase, the director owned 14,363 shares in the company, valued at $921,817.34. The trade was a 229.20% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

GE HealthCare Technologies Stock Performance

GEHC stock traded down $0.05 during mid-day trading on Tuesday, reaching $64.18. The company had a trading volume of 4,011,279 shares, compared to its average volume of 4,231,655. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The stock has a market capitalization of $29.19 billion, a P/E ratio of 15.35, a P/E/G ratio of 1.45 and a beta of 0.74. GE HealthCare Technologies Inc. has a one year low of $58.75 and a one year high of $89.77. The stock’s 50-day simple moving average is $68.33 and its two-hundred day simple moving average is $76.18.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). The firm had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in GEHC. Laurel Wealth Advisors LLC bought a new position in GE HealthCare Technologies during the 4th quarter valued at $26,000. Optima Capital LLC bought a new stake in shares of GE HealthCare Technologies in the 4th quarter worth $27,000. Godfrey Financial Associates Inc. acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at $27,000. Montag A & Associates Inc. lifted its holdings in shares of GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC boosted its stake in GE HealthCare Technologies by 331.6% during the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 262 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on GEHC. UBS Group raised GE HealthCare Technologies from a “sell” rating to a “neutral” rating and cut their price target for the company from $75.00 to $69.00 in a report on Thursday, May 21st. Morgan Stanley raised their target price on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 4th. HSBC cut their target price on GE HealthCare Technologies from $100.00 to $90.00 in a research note on Thursday, April 30th. Rothschild & Co Redburn reduced their price target on GE HealthCare Technologies from $110.00 to $98.00 in a research report on Thursday, April 30th. Finally, BTIG Research decreased their price target on GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Nine research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $80.21.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.